SYRE – spyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Bronstein, Gewirtz & Grossman, LLC Encourages Spyre Therapeutics, Inc. (SYRE) Investors to Inquire about Securities Investigation
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Spyre Therapeutics, Inc. (SYRE) And Encourages Investors to Reach Out
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE
Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Form 8-K Spyre Therapeutics, Inc. For: Nov 18
Form 424B5 Spyre Therapeutics, Inc.
Form 424B5 Spyre Therapeutics, Inc.
Form 10-Q/A Spyre Therapeutics, Inc. For: Sep 30
Form 10-Q/A Spyre Therapeutics, Inc. For: Jun 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.